Agilent Technologies (A) EBT Margin (2010 - 2026)

Agilent Technologies (A) has reported EBT Margin for 17 consecutive years, with 22.23% the latest figure, recorded in Q2 2026.

• In Q2 2026, EBT Margin rose 665.0% year-over-year to 22.23%; the TTM figure through Apr 2026 stood at 21.85% (up 116.0% YoY), while the FY2025 annual figure was 20.65%, down 271.0% from the prior year.
• EBT Margin grew to 22.23% in Q2 2026 per A's latest filing, from 20.24% in the prior quarter.
• Across five years, EBT Margin topped out at 24.88% in Q4 2023 and bottomed at 7.89% in Q3 2023.
• Historically, EBT Margin has averaged 21.32% across 5 years, with a median of 22.1% in 2023.
• Annual changes were most pronounced in 2023 — EBT Margin plunged 1521 bps — and 2024, when it soared 1384 bps.
• Agilent Technologies' EBT Margin stood at 24.61% in 2022, then grew by 1 bps to 24.88% in 2023, then retreated by 5 bps to 23.57% in 2024, then increased by 1 bps to 23.75% in 2025, then declined by 6 bps to 22.23% in 2026.
• Business Quant data shows A's EBT Margin at 22.23% in Q2 2026, 20.24% in Q1 2026, and 23.75% in Q4 2025.